Efficacy of Red Blood Cell Exchange as Adjunctive Treatment for Hypoxemia and Survival Rate of Patients With Severe Coronavirus-2 Disease: An Open-Labeled Phase 2 Randomized Clinical Trial

BACKGROUND: Severe acute respiratory syndrome (SARS) coronavirus-2 may infect red blood cells (RBCs) and impact oxygenation. We aimed to evaluate the efficacy of RBC exchange as an adjunctive treatment for hypoxemia and the survival rate of patients with severe coronavirus disease 2019 (COVID-19). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Aminianfar, Mohammad, Soleiman-Meigooni, Saeed, Hamidi-Farahani, Ramin, Darvishi, Mohammad, Hoseini-Shokouh, Seyyed Javad, Asgari, Ali, Faraji-Hormozi, Syrous, Asli, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304762/
https://www.ncbi.nlm.nih.gov/pubmed/35872770
http://dx.doi.org/10.3389/fmed.2022.899593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304762/
https://www.ncbi.nlm.nih.gov/pubmed/35872770
http://dx.doi.org/10.3389/fmed.2022.899593

Ejemplares similares